Literature DB >> 11434669

Post-surgical ablation of thyroid residues with radioiodine in Ukrainian children and adolescents affected by post-Chernobyl differentiated thyroid cancer.

V Oliynyk1, O Epshtein, T Sovenko, M Tronko, R Elisei, F Pacini, A Pinchera.   

Abstract

Post-surgical ablation of thyroid residues with 131-iodine (131-I) is usually recommended after near-total thyroidectomy in high-risk patients, including children, with differentiated thyroid cancer (DTC). We report here the results of post-surgical radioiodine thyroid ablation in 249 children and adolescents of Ukraine with post-Chernobyl DTC initially treated with near-total thyroidectomy at the Institute of Endocrinology and Metabolism in Kiev, during a 2-year period. The patients' age at the time of the Chernobyl accident (1986), ranged from <1 to 14 yr in 223 subjects (children) and from 15 to 18 yr in 26 subjects (adolescents). Six weeks after surgery a diagnostic 131-I whole body scan revealed the presence of residual thyroid tissue in all cases. All patients received one or more courses of radioiodine therapy, for a total of 468 courses. One hundred and twenty-nine out of 249 patients (51.8%) were successfully ablated. The total number of treatment courses needed in these patients was 219. Most patients required multiple doses of radioiodine, only 63 required a single dose. One hundred and twenty patients (48.2%) treated with radioiodine were not ablated and are still under treatment program. The clinical features and the amount of thyroid residue were not different in ablated or not-ablated patients. Our results indicate that in this particular population of post-Chernobyl thyroid carcinomas, thyroid ablation is a rather difficult task. Only 51.8% were successfully ablated. Possible explanation for this finding may be the young age of the patients, other particular features of post-Chernobyl thyroid carcinoma or technical aspects, such as less radical surgical procedures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434669     DOI: 10.1007/BF03351045

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

Review 1.  Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer.

Authors:  H R Maxon; H S Smith
Journal:  Endocrinol Metab Clin North Am       Date:  1990-09       Impact factor: 4.741

Review 2.  The use of radioactive iodine in patients with papillary and follicular thyroid cancer.

Authors:  L Wartofsky; S I Sherman; J Gopal; M Schlumberger; I D Hay
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

Review 3.  Papillary and follicular thyroid carcinoma.

Authors:  M J Schlumberger
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

4.  Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma.

Authors:  M Schlumberger; E Baudin
Journal:  Eur J Endocrinol       Date:  1998-03       Impact factor: 6.664

5.  Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: statistical data and clinicomorphologic characteristics.

Authors:  M D Tronko; T I Bogdanova; I V Komissarenko; O V Epstein; V Oliynyk; A Kovalenko; I A Likhtarev; I Kairo; S B Peters; V A LiVolsi
Journal:  Cancer       Date:  1999-07-01       Impact factor: 6.860

6.  Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus.

Authors:  Y Nikiforov; D R Gnepp
Journal:  Cancer       Date:  1994-07-15       Impact factor: 6.860

7.  Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer.

Authors:  F Pacini; R Lari; S Mazzeo; L Grasso; D Taddei; A Pinchera
Journal:  Clin Endocrinol (Oxf)       Date:  1985-10       Impact factor: 3.478

8.  Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France.

Authors:  F Pacini; T Vorontsova; E P Demidchik; E Molinaro; L Agate; C Romei; E Shavrova; E D Cherstvoy; Y Ivashkevitch; E Kuchinskaya; M Schlumberger; G Ronga; M Filesi; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

Review 9.  The use of radioactive iodine in thyroid carcinoma.

Authors:  A W Goolden
Journal:  Eur J Cancer Clin Oncol       Date:  1988-02

10.  Radioiodine therapy for well-differentiated thyroid cancer: a quantitative dosimetric evaluation for remnant thyroid ablation after surgery.

Authors:  A M Samuel; B Rajashekharrao
Journal:  J Nucl Med       Date:  1994-12       Impact factor: 10.057

View more
  2 in total

1.  Clinical behavior of radiation-induced thyroid cancer: factors related to recurrence.

Authors:  Soe Naing; Barbara J Collins; Arthur B Schneider
Journal:  Thyroid       Date:  2009-05       Impact factor: 6.568

2.  Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology.

Authors:  F Pacini; E Brianzoni; C Durante; R Elisei; M Ferdeghini; L Fugazzola; S Mariotti; G Pellegriti
Journal:  J Endocrinol Invest       Date:  2015-08-12       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.